Skip to main content

Peer Review reports

From: Sorafenib versus Transarterial chemoembolization for advanced-stage hepatocellular carcinoma: a cost-effectiveness analysis

Original Submission
18 Aug 2017 Submitted Original manuscript
25 Jan 2018 Author responded Author comments - Shuling Chen
11 Dec 2017 Reviewed Reviewer Report - Jagpreet Chhatwal
28 Dec 2017 Reviewed Reviewer Report - Rudolf Stauber
Resubmission - Version 2
25 Jan 2018 Submitted Manuscript version 2
21 Mar 2018 Author responded Author comments - Shuling Chen
16 Feb 2018 Reviewed Reviewer Report - Jagpreet Chhatwal
26 Feb 2018 Reviewed Reviewer Report - Rudolf Stauber
Resubmission - Version 3
21 Mar 2018 Submitted Manuscript version 3
Publishing
26 Mar 2018 Editorially accepted
5 Apr 2018 Article published 10.1186/s12885-018-4308-7

You can find further information about peer review here.

Back to article page